IP Library Granted Patent US 7,700,308
Granted Patent B2
US 7,700,308 · App. 11/214,474 · Granted Apr 20, 2010

Methods for determining susceptibility to dental caries

Assignee: University of Washington
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,700,308
App. No.
11/214,474
Granted
Apr 20, 2010
Kind
B2
Abstract

The present invention provides methods for determining whether a human being is susceptible to dental caries. The methods each include the steps of measuring the amount of α-defensins HNP 1, HNP 2 and HNP 3 in saliva obtained from a human being, and determining whether a reduced amount of the α-defensins HNP 1, HNP 2 and HNP 3 is present in the saliva, thereby determining whether the human being is susceptible to dental caries.

Claims (15)

1. A method of determining whether a human child is susceptible to dental caries, the method comprising the steps of:

(a) measuring the amount of α-defensins HNP 1, HNP 2 and HNP 3 in saliva obtained from a human child; and

(b) comparing the measured amount of the α-defensins HNP 1, HNP 2 and HNP 3 to a reference value, wherein an amount less than a reference value of 0.4 μg of HNP 1, HNP 2 and HNP 3 per milliliter of saliva indicates the human child is susceptible to dental caries.

2. A method of claim 1 , wherein the amount of α-defensins HNP 1, HNP 2 and HNP 3 is measured using a method selected from the group consisting of enzyme linked immunoassay, mass spectrometry, high pressure liquid chromatography, dot immunoassay and a combination of gel electrophoresis and western blot.

3. A method of claim 1 , wherein the amount of α-defensins HNP 1, HNP 2 and HNP 3 is measured using an enzyme linked immunoassay.

4. A method of claim 1 , wherein the α-defensins HNP 1, HNP 2 and HNP 3 are each at least 90% identical to an HNP 1 α-defensin peptide consisting of the amino acid sequence set forth in SEQ ID NO:1.

5. A method of claim 1 , wherein the α-defensins HNP 1, HNP 2 and HNP 3 are each at least 95% identical to an HNP 1 α-defensin peptide consisting of the amino acid sequence set forth in SEQ ID NO:1.

6. A method of claim 1 , wherein the α-defensins HNP 1, HNP 2 and HNP 3 are each at least 99% identical to an HNP 1 α-defensin peptide consisting of the amino acid sequence set forth in SEQ ID NO:1.

7. A method of claim 1 , wherein an amount of the HNP 1, HNP 2 and HNP 3 peptides less than 0.3 μg per milliliter saliva indicates susceptibility of the human child to dental caries.

8. A method of claim 1 , wherein an amount of the HNP 1, HNP 2 and HNP 3 peptides less than 0.2 μg per milliliter saliva indicates susceptibility of the human child to dental caries.

9. A method of claim 1 , wherein an amount of the HNP 1, HNP 2 and HNP 3 peptides less than 0.1 μg per milliliter saliva indicates susceptibility of the human child to dental caries.

10. A method of claim 1 , wherein an amount of the HNP 1, HNP 2 and HNP 3 peptides less than 0.3 μg per milligram total salivary protein indicates susceptibility of the human child to dental caries.

11. A method of claim 1 , wherein an amount of the HNP 1, HNP 2 and HNP 3 peptides less than 0.2 μg per milligram total salivary protein indicates susceptibility of the human child to dental caries.

12. A method of claim 1 , wherein an amount of the HNP 1, HNP 2 and HNP 3 peptides less than 0.1 μg per milligram total salivary protein indicates susceptibility of the human child to dental caries.

13. A method of claim 1 , wherein the saliva obtained is unstimulated saliva.

Assignments (4)
CONFIRMATORY LICENSE Recorded Sep 25, 2012
From: UNIVERSITY OF WASHINGTON / CENTER FOR COMMERICALIZATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029034/0222 →
CONFIRMATORY LICENSE Recorded Dec 23, 2011
From: UNIVERSITY OF WASHINGTON / CENTER FOR COMMERCIALIZATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027439/0454 →
CONFIRMATORY LICENSE Recorded Sep 16, 2008
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021533/0590 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2005
From: DALE-CRUNK, BEVERLY A.; KIMBALL, JANET R.; TAO, RENCHAUN
To: UNIVERSITY OF WASHINGTON
Reel/Frame 016770/0542 →
Continuity (2)
Provisional Application 6061057900 · Sep 16, 2004
Related Publication 20060057654A1 · Mar 16, 2006